|
Six are Brown’s first graduates in new concentration of biomedical
engineering
Graduate program and center for the discipline gain approval
by Scott J. Turner
A great academic program
might be one that allows students to study a cutting-edge discipline, work on
attention-grabbing science and get to know the faculty, staff and graduate
students who teach and conduct research.
These are the traits of the
new undergraduate concentration in biomedical engineering, say members of its
first graduating class, who received their diplomas May 27. (Below, from left, Amanda Lease, Jahi Gist, Ian Kaplan, Professor Lysaght, Nick Marcantonio, Meera Shah and Even Scott)
 The concentration, which
weds biology, engineering and medicine, evolved three years ago out of the
former bioengineering concentration.
Senior Ian Kaplan said he
was in the right place at the right time when the program began in 1998. He
started freshman year as an engineering student. When it wasn’t exactly
what he wanted, Kaplan considered switching to biology. His adviser told him
about biomedical engineering.
“It was the perfect balance between biology and
engineering,” Kaplan said. “This field is booming. It is important
to have Brown folks coming into it.”
After graduation, Kaplan
will work for a year in the lab of faculty member Jeffrey Morgan, M.D. Kaplan
will study tissue-engineered skin grafts to treat burn victims and diabetics
with skin ulcers. Then he hopes to enter graduate school.
Biomedical engineering
builds upon five decades of Brown accomplishment and leadership in the field,
said professor and program head Michael Lysaght. Important areas of strength at
Brown include biomaterials, quantitative physiology, drug and gene delivery,
orthopedic implants, organ replacement, neuroengineering and tissue
engineering, he said.
The coming half-century is
likely to be identified as the “age of biotechnology,” according to
Lysaght. “Newer and better ways of doing things with biology and in
medicine will impact our lives as much in the coming decades as did digital
technology in the previous 50 years and the period of industrialization for 150
years before that. From vaccines to prevent epidemics, drugs to lower the risk
of heart attack, and the widespread availability of replacement body parts, the
fruits of biomedical engineering are all around us.”
Last semester, all six
graduating students took Biology 108, which is an organ replacement course
taught by Lysaght.
“That class brings everything together,” said
senior Nicholas Marcantonio, who will begin a doctoral program in biological
engineering at MIT. “We looked at dealing with biological problems from
an engineering standpoint, but within the framework of ethics, economics,
politics, societal impacts and other issues.”
Brown offers a special
benefit of being able to teach sound engineering fundamentals in the broader
context of a liberal education, Lysaght said. In the future, “leadership
positions in this field will go to strong engineers who can also think clearly,
decide fairly and communicate effectively,” he said.
Senior Meera Shah was
attracted to the “immediate social benefit” of biomedical
engineering. “You conduct research where you can ultimately see the
fruits of your labors in someone’s good health,” she said.
Biomedical engineering is
one of the most attractive concentrations for undergraduates in the Division of
Engineering, said Dean Rodney J. Clifton. “Combining engineering sciences
and life sciences opens up many career opportunities, appeals to idealistic goals
of many of our students, and is intellectually satisfying for students with
interest and aptitude in mathematics and science.”
Next semester there will be
30 concentrators in biomedical engineering at the junior and senior levels. And
recently, President Simmons approved a Center for Biomedical Engineering, and the Board of Fellows of the Brown Corporation approved a graduate
program in biomedical engineering.
Lysaght will lead both entities.
“These efforts are designed to provide infrastructure,
and a coherent, efficient framework to our strengths,” said Lysaght. He
expects students from elsewhere in the Brown graduate system to begin
transferring into biomedical engineering immediately.
“The new Center for Biomedical Engineering and the
graduate program will do much to take advantage of opportunities for
collaborative research and teaching by faculty members and students,”
said Clifton.
Lysaght has brought in
recent grant support from the Whittaker Foundation and the McCune Foundation.
He has also helped recruit four new faculty members whose primary research and
teaching interests are in biomedical engineering.
Each initiative in
biomedical engineering is an outgrowth of the collective vision of Dean Clifton
and Donald J. Marsh, dean of medicine and biological sciences, Lysaght said.
All three initiatives – the center, the concentration and the graduate
program – are joint undertakings by the two divisions.
“This is a
competitive advantage for Brown relative to programs in biomedical engineering
that lack the clinical relevance, afforded by close collaboration with a
medical school,” Lysaght said.
For Shah, “there are
many things that you can do with this training. You can work in law, practice
medicine, and work as an academic or in industry. You can make prostheses,
pharmaceuticals, engineer tissues or work in immunology.”
Shah will spend the summer
studying nerve cells in the lab of Assistant Professor Diane Hoffman-Kim. Among
the other three graduates in the concentration, one will enter graduate school,
another will teach in high school for a year before entering a doctoral program
and the third will conduct research in a lab overseas.
Disciplines that border
biology have engineering applications, Shah said. “Think of any device
you see in the hospital or any drug delivered. There are so many aspects of
this field to like. That is what I find awesome about it.”
|